146 related articles for article (PubMed ID: 33974462)
1. Sema4D correlates with tumour immune infiltration and is a prognostic biomarker in bladder cancer, renal clear cell carcinoma, melanoma and thymoma.
Lu Q; Cai P; Yu Y; Liu Z; Chen G; Zeng Z
Autoimmunity; 2021 Aug; 54(5):294-302. PubMed ID: 33974462
[TBL] [Abstract][Full Text] [Related]
2. Semaphorin-plexin signalling genes associated with human breast tumourigenesis.
Gabrovska PN; Smith RA; Tiang T; Weinstein SR; Haupt LM; Griffiths LR
Gene; 2011 Dec; 489(2):63-9. PubMed ID: 21925246
[TBL] [Abstract][Full Text] [Related]
3. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
[TBL] [Abstract][Full Text] [Related]
4. Semaphorin 4D promotes the proliferation and metastasis of bladder cancer by activating the PI3K/AKT pathway.
Lu JJ; Su YW; Wang CJ; Li DF; Zhou L
Tumori; 2019 Jun; 105(3):231-242. PubMed ID: 30674231
[TBL] [Abstract][Full Text] [Related]
5. Sema4D expression and secretion are increased by HIF-1α and inhibit osteogenesis in bone metastases of lung cancer.
Chen WG; Sun J; Shen WW; Yang SZ; Zhang Y; Hu X; Qiu H; Xu SC; Chu TW
Clin Exp Metastasis; 2019 Feb; 36(1):39-56. PubMed ID: 30617444
[TBL] [Abstract][Full Text] [Related]
6. Potential Prognostic Predictors and Molecular Targets for Skin Melanoma Screened by Weighted Gene Co-expression Network Analysis.
Chen S; Liu Z; Li M; Huang Y; Wang M; Zeng W; Wei W; Zhang C; Gong Y; Guo L
Curr Gene Ther; 2020; 20(1):5-14. PubMed ID: 32416689
[TBL] [Abstract][Full Text] [Related]
7. Plexin-B1 plays a redundant role during mouse development and in tumour angiogenesis.
Fazzari P; Penachioni J; Gianola S; Rossi F; Eickholt BJ; Maina F; Alexopoulou L; Sottile A; Comoglio PM; Flavell RA; Tamagnone L
BMC Dev Biol; 2007 May; 7():55. PubMed ID: 17519029
[TBL] [Abstract][Full Text] [Related]
8. A pan-cancer study of class-3 semaphorins as therapeutic targets in cancer.
Zhang X; Klamer B; Li J; Fernandez S; Li L
BMC Med Genomics; 2020 Apr; 13(Suppl 5):45. PubMed ID: 32241267
[TBL] [Abstract][Full Text] [Related]
9. LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma.
Sun K; Chen RX; Li JZ; Luo ZX
Hereditas; 2022 Mar; 159(1):16. PubMed ID: 35241179
[TBL] [Abstract][Full Text] [Related]
10. Semaphorin 4D and hypoxia-inducible factor-1α overexpression is related to prognosis in colorectal carcinoma.
Wang JS; Jing CQ; Shan KS; Chen YZ; Guo XB; Cao ZX; Mu LJ; Peng LP; Zhou ML; Li LP
World J Gastroenterol; 2015 Feb; 21(7):2191-8. PubMed ID: 25717256
[TBL] [Abstract][Full Text] [Related]
11. Antibody Blockade of Semaphorin 4D Promotes Immune Infiltration into Tumor and Enhances Response to Other Immunomodulatory Therapies.
Evans EE; Jonason AS; Bussler H; Torno S; Veeraraghavan J; Reilly C; Doherty MA; Seils J; Winter LA; Mallow C; Kirk R; Howell A; Giralico S; Scrivens M; Klimatcheva K; Fisher TL; Bowers WJ; Paris M; Smith ES; Zauderer M
Cancer Immunol Res; 2015 Jun; 3(6):689-701. PubMed ID: 25614511
[TBL] [Abstract][Full Text] [Related]
12. [Correlation and clinical significance of expressions of HIF-1α and Sema4D in colorectal carcinoma tissues].
Mu L; Wang J; Guo X; Zheng S; Shan K; Jing C; Li L
Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Apr; 17(4):388-92. PubMed ID: 24760652
[TBL] [Abstract][Full Text] [Related]
13. Semaphorin 4D promotes bone invasion in head and neck squamous cell carcinoma.
Takada H; Ibaragi S; Eguchi T; Okui T; Obata K; Masui M; Morisawa A; Takabatake K; Kawai H; Yoshioka N; Hassan NMM; Shimo T; Hu GF; Nagatsuka H; Sasaki A
Int J Oncol; 2017 Aug; 51(2):625-632. PubMed ID: 28656278
[TBL] [Abstract][Full Text] [Related]
14. Association between prognosis and SEMA4D/Plexin-B1 expression in various malignancies: A meta-analysis.
Yang Y; Wang J; Li H; Liu L; Yao M; Xiao T
Medicine (Baltimore); 2019 Feb; 98(7):e13298. PubMed ID: 30762724
[TBL] [Abstract][Full Text] [Related]
15. Expression of neuroimmune semaphorins 4A and 4D and their receptors in the lung is enhanced by allergen and vascular endothelial growth factor.
Smith EP; Shanks K; Lipsky MM; DeTolla LJ; Keegan AD; Chapoval SP
BMC Immunol; 2011 May; 12():30. PubMed ID: 21595947
[TBL] [Abstract][Full Text] [Related]
16. Reduced expression of semaphorin 4D and plexin-B in breast cancer is associated with poorer prognosis and the potential linkage with oestrogen receptor.
Malik MF; Ye L; Jiang WG
Oncol Rep; 2015 Aug; 34(2):1049-57. PubMed ID: 26035216
[TBL] [Abstract][Full Text] [Related]
17. Semaphorin 4D, a lymphocyte semaphorin, enhances tumor cell motility through binding its receptor, plexinB1, in pancreatic cancer.
Kato S; Kubota K; Shimamura T; Shinohara Y; Kobayashi N; Watanabe S; Yoneda M; Inamori M; Nakamura F; Ishiguro H; Nakaigawa N; Nagashima Y; Taguri M; Kubota Y; Goshima Y; Morita S; Endo I; Maeda S; Nakajima A; Nakagama H
Cancer Sci; 2011 Nov; 102(11):2029-37. PubMed ID: 21812859
[TBL] [Abstract][Full Text] [Related]
18. Semaphorin 4D provides a link between axon guidance processes and tumor-induced angiogenesis.
Basile JR; Castilho RM; Williams VP; Gutkind JS
Proc Natl Acad Sci U S A; 2006 Jun; 103(24):9017-22. PubMed ID: 16754882
[TBL] [Abstract][Full Text] [Related]
19. Roles of Sema4D and Plexin-B1 in tumor progression.
Ch'ng ES; Kumanogoh A
Mol Cancer; 2010 Sep; 9():251. PubMed ID: 20858260
[TBL] [Abstract][Full Text] [Related]
20. SEMA4D Knockdown Attenuates
Rezaeepoor M; Rashidi G; Pourjafar M; Mohammadi C; Solgi G; Najafi R
Biomed Res Int; 2021; 2021():8507373. PubMed ID: 34337054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
